Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Pharma industry should reduce dependence on import of raw materials: Rajesh Agarwal
Pharma industry should reduce dependence on import of raw materials: Rajesh Agarwal
BusinessLine

India's pharmaceutical industry needs to reduce its critical dependence on imports used in the manufacturing process, while insulating exports from global geopolitical uncertainties, Rajesh Agarwal, Secretary, Department of Commerce Ministry of…

indianexpress.com - Ravi Dutta Mishra - US announces 100% tariff on patented pharma; limited impact on India
US announces 100% tariff on patented pharma; limited impact on India
The Indian Express

3 min read New Delhi Make us preferred source on Google THE US on Thursday announced a 100% tariff on import of patented pharmaceuticals and associated ingredients starting July 31 on grounds that Washington is heavily reliant on imports, which…

thehindubusinessline.com - India's pharma exports cross $28 bn till Feb, grow over 5%
India's pharma exports cross $28 bn till Feb, grow over 5%
BusinessLine

India's pharmaceutical exports stood at over $28 billion up to February of the current financial year, registering a growth of more than 5 per cent compared to the same period last year, a top official said on Saturday. K Raja Bhanu, Director…

statnews.com - Ed Silverman - Pharmalittle: We're reading about Trump's drug tariffs, a U.S.-U.K. pharma trade deal, and more
Pharmalittle: We're reading about Trump's drug tariffs, a U.S.-U.K. pharma trade deal, and more
STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest so far. We plan to tidy up around the castle, promenade…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Receives Consensus Recommendation of 'Moderate Buy' from Analysts
Ascendis Pharma A/S (NASDAQ:ASND) Receives Consensus Recommendation of 'Moderate Buy' from Analysts
MarketBeat

Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) have been given a consensus rating of 'Moderate Buy' by the nineteen ratings firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated…

swissinfo.ch - swissinfo.ch - Swiss metals and machine industry worried about new US tariff rules
Swiss metals and machine industry worried about new US tariff rules
www.swissinfo.ch

“President Trump has strengthened tariffs on imported aluminum, steel, and copper to protect the national security of the United States, including the economic resilience of vital industries and the financial position of American…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0427 ET – The U.S.'s 100% pharmaceutical tariffs are likely to have limited effect on the sector, says…

newsbytesapp.com - Akash Pandey - Indian pharma exports show resilience, near $29B with steady growth
Indian pharma exports show resilience, near $29B with steady growth
NewsBytes

What's the story India 's pharmaceutical exports have shown remarkable resilience this financial year, nearing the $29 billion mark by February. This growth comes even as global markets continue to be volatile. K Raja Bhanu, Director General of the…

wwd.com - Kate Nishimura - Ratification of EU-US Trade Deal Could Be Imminent Amid White House's Latest Tariff Adjustments
Ratification of EU-US Trade Deal Could Be Imminent Amid White House's Latest Tariff Adjustments
WWD

The ratification of a trade pact between the United States and the European Union may be imminent after President Donald Trump this week revised U.S. duties on key import categories. On Thursday, the one-year anniversary of “Liberation…

gizmodo.com - Matthew Phelan - Judge Kills Lawsuit Against Infamous Study That Might Have Increased Teen Suicides
Judge Kills Lawsuit Against Infamous Study That Might Have Increased Teen Suicides
Gizmodo | The Future Is Here

A war has been waged for over two decades, both in the courts and in the pages of peer-reviewed medical journals, over a controversial study that recommended the antidepressant Paxil as “well tolerated” and an…

deccanchronicle.com - Sangeetha G - US Levies 100 pc Duty On Patented Drugs; Generics Exempted For Now
US Levies 100 pc Duty On Patented Drugs; Generics Exempted For Now
Deccan Chronicle

Chennai: The US has imposed 100 per cent duty on the import of patented pharmaceuticals and associated pharmaceutical ingredients. Generic drugs have been kept out of the duty for the time being. But, if pharma companies increasingly seek…

thehindu.com - Pti - Patented drug tariffs: India more or less shielded, says GTRI
Patented drug tariffs: India more or less shielded, says GTRI
The Hindu

India is unlikely to be significantly impacted by U.S. President Donald Trump's announcement of 100% tariffs on certain patented drugs, as the country primarily exports low-cost generic medicines to America, think tank GTRI said on Friday (April 3…

deccanchronicle.com - PTI - India's Generic Export Strength Shields it From U.S. Patented Drug Tariffs
India's Generic Export Strength Shields it From U.S. Patented Drug Tariffs
Deccan Chronicle

The order, issued on April 2, 2026, builds on a Section 232 investigation launched on May 1, 2025, which cited national security risks from dependence on foreign drug supplies. The Global Trade Research Initiative (GTRI) said the move has left…

thehindubusinessline.com - Apollo Hospitals gets NCLT nod for restructuring of digital and pharmacy businesses
Apollo Hospitals gets NCLT nod for restructuring of digital and pharmacy businesses
BusinessLine

Apollo Hospitals Enterprise has received a key regulatory nod required for its proposed corporate restructuring. The healthcare major informed exchanges on Friday that the National Company Law Tribunal (NCLT), Chennai bench, has approved its…

marketbeat.com - BTC Capital Management Inc. Trims Position in Johnson & Johnson $JNJ
BTC Capital Management Inc. Trims Position in Johnson & Johnson $JNJ
MarketBeat

BTC Capital Management Inc. reduced its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 5.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 91,064 shares of the company's stock after selling 5,220…

Receive a Daily briefing on Pharma Industry News

Get Started